Her Discovery Wasn’t Alien Life, but Science Has Never Been the Same
The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.
Oneok upgraded at Wolfe, as discounted valuation brings buying opportunity
Oneok upgraded at Wolfe Research, saying the stock has fallen out of favor on near-term Bakken headwinds and its valuation has quickly shifted to a big discount to large-cap peers.
Triumph Group downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Myles Walton downgraded Triumph Group (TGI) to Peer Perform from Outperform without a price target after the company ...
Spinoff trends like Honeywell's will continue, says Wolfe Research's Chris Senyek
CNBC’s Seema Mody and Chris Senyek, Wolfe Research chief investment strategist, join 'Power Lunch' to discuss the Honeywell ...
D-Wave Quantum (QBTS): ‘Quantum Realized’ Conference Showcases Real-World AI Impact
We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...
Cash App, Venmo app downloads decline
Consumer downloads of apps like Cash App and Venmo dropped in the fourth quarter compared to the year-ago period, data from ...
Fintel on MSN6d
Wolfe Research Initiates Coverage of Zenas BioPharma (ZBIO) with Outperform Recommendation
Fintel reports that on February 4, 2025, Wolfe Research initiated coverage of Zenas BioPharma (NasdaqGS:ZBIO) with a ...
Should Comcast split into three? This analyst says a breakup would mean big upside.
Today he's back with another open letter urging management to separate into three businesses. "Three public companies with ...
Zenas BioPharma initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Zenas BioPharma (ZBIO) with an Outperform rating and $19 price target After its IPO in September 2024, ...